Medolac Laboratories opened its newly designed headquarters and flagship center of operations in Lake Oswego, Oregon
. The cutting edge facility includes corporate offices, a lab, freezer facilities and clean room environments essential for the development and processing of human donor milk derived products.
The firm develops and commercializes innovative, human donor milk products for clinical use, applying proprietary biopharmaceutical
processing methods that preserve the immune components in human milk.
Elena Medo, CEO/Founder, said, "The opening of Medolac's new headquarters
, lab, and processing facility mark key milestones in the company's commitment to end the longstanding shortage of donor milk and make innovative, adapted donor milk products available and accessible for use in neonatal intensive care settings."
Company officials said “this new facility will help Medolac do its part to address the plight of 15 million preterm babies born each year, detailed in a published report by the United Nations, showing that many preterm infants do not survive simply due to the lack of access to appropriate nutrition. Donor milk is often unavailable in neonatal settings, quite costly and because neonatal intensive care units are often located far away from the baby's home, many infants have no access to their mother or her milk."
Medolac said it plans to ramp up development of a comprehensive and innovative suite of neonatal nutrition products at its new facility in the coming months to respond to the urgent need for human milk products for special nutritional and therapeutic uses.